Rxo Operating Expenses Growth & History (RXO)

Rxo's operating expenses was $1.21B for fiscal 2025.

View full Rxo company overview

Rxo annual operating expenses history

Rxo annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31$1.21B$169.0M+16.23%
20242024-12-31$1.04B$120.0M+13.03%
20232023-12-31$921.0M−$128.0M−12.20%
20222022-12-31$1.05B$233.0M+28.55%
20212021-12-31$816.0M$87.0M+11.93%
20202020-12-31$729.0M

Rxo operating expenses trends

Over the last five fiscal years, Rxo's operating expenses increased from $729.0M to $1.21B, a change of $481.0M. The latest reported quarter, Q2 2026, shows $301.0M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Rxo source filings ↗

Community posts

It’s quiet here.

No posts about RXO yet. Start the conversation.

Write the first post